% | $
Quotes you view appear here for quick access.

pSivida Corp. Message Board

  • ha7med ha7med Dec 25, 2010 9:57 AM Flag

    PSDV Partnership with Pfizer


    pSivida has a worldwide collaborative research and license agreement with Pfizer Inc. to develop certain ophthalmic products utilizing our drug delivery technology.

    Alimera Sciences
    pSivida has licensed certain Medidur™ drug delivery technology to Alimera Sciences, Inc. for the development of Iluvien™ and certain other ophthalmic products. Iluvien, fluocinolone acetonide (FA) for the treatment of diabetic macular edema (DME), is pSivida’s lead development product and is in fully recruited Phase III clinical trials.

    Bausch & Lomb
    pSivida has licensed two FDA approved products and their underlying technologies to Bausch & Lomb Incorporated: Retisert® for the treatment of posterior uveitis and Vitrasert® for the treatment of AIDS-related cytomegalovirus (CMV) retinitis.

    This topic is deleted.
3.23+0.06(+1.89%)Sep 27 3:59 PMEDT